6 / 14
Volume 3
Dentistry and Craniofacial Research
ISSN: 2576-392X
Page 58
JOINT EVENT
August 16-17, 2018 Madrid, Spain
&
24
th
International Conference on
Dental Public Health & Dental Hygiene
3
rd
International Conference on
General Practice & Primary Care
General Practice 2018
Dental Public Health 2018
August 16-17, 2018
J Dent Craniofac Res 2018, Volume 3
DOI: 10.21767/2576-392X-C2-006
Study of effect of poly (vinylpyrrolidone)-iodine (PVP-I) 2%as an anti-oedematous agent in thirdmolar
surgery
Kanwaldeep Singh Soodan
M M University, India
A
single blind randomized control trial was carried out on 50 healthy outpatients who required surgical removal of
mandibular third molars under local anesthesia were selected. The patients were divided into two groups (n=25), the
treatment (PVP-I) and control group (normal saline). The treatment group patients were irrigated using PVP-I 2% (w/v)
(Betadine, Win- Medicare, India) during bone guttering and tooth sectioning. The control group patients were irrigated with
saline (sodium chloride 0.9%, w/v; parental drugs, India) only. Procedures that exceeded more than one hour were excluded
from the study. Using Pedersen difficulty index, patients with moderately difficulty index were chosen. All parameters for
swelling were recorded preoperatively, on the first, second and seventh postoperative days for both procedures. The data were
statistically analyzed using SPSS (version 22.0) software. Independent t-test was applied for operative time in minutes and the
two groups matched (p>0.05) for operative time. For change in swelling, T-tests was applied and we found increase in swelling
in saline group which was highly significant for change from preoperative to day two (p=.005) and from preoperative to day
seven (p-value<.001). Mean for Pedersen index for Betadine and saline group was found out to be same (P=1). PVP-I 2% was
found out to be significantly reducing swelling as compared to saline suggesting that it acts as an anti-oedematous agent in
mandibular third molar surgery.
dr.kanwal@rediffmail.com